Andrew Freedman, CFA, Equity Research Analyst at Hedgeye Risk
Management, and Marquette AIM Class of 2011 Graduate, was the Bloomberg Top
News Feed Yesterday!
Andrew Freedman has been with Hedgeye,
located in Stamford, CT, since 2014. He was an analyst with Clearbrook Consulting in NYC prior to moving to Hedgeye.
 |
| Andrew Freedman, AIM Alumnus |
Dr. David Krause, Marquette AIM program director, said "From the day he entered the AIM program, Andrew was all about equities. He loved investing and had I left him, he probably would have pitched a new stock every week. Andrew was a stock junkie, so I am not surprised by this accomplishment. Way to go!"
Andrew primarily covers U.S. healthcare
and information technology equities. He has extensive knowledge of the healthcare
IT industry (EMR, population health, value-based care, telehealth, business
intelligence, outsourcing and revenue cycle management). Life most investment research analysts today
he has experience using SQL to analyze and manipulate large datasets.
His primary coverage lists
includes: ATHN, CERN, MDRX, CPSI, QSII, RCM, TDOC, HQY, OMCL, EVH, MDSO, WAGE, HCA,
THC, LPNT, CYH, MD, SGRY, ZBH, SYK, DGX, LH, EXAS, MYGN, and HOLX.
